News | June 08, 2024
GSK acquires oligonucleotide drug startup Elsie
Oligonucleotides are a unique modality with potential to address hard-to-treat diseases with high unmet need
Oligonucleotides are a unique modality with potential to address hard-to-treat diseases with high unmet need
The state-of-the-art facility is equipped with best-in-class equipment and control systems
Merck shared updates on the company’s oncology pipeline and focused R&D approach
Partnership to facilitate collaborative research in academia and industry to further progress in life sciences
Bluecrux's digital supply chain twin technology, Axon, plays a critical role in Sanofi's digital supply chain transformation.
ALS is a rare, progressive and fatal neurodegenerative disease, with an average life expectancy of 3 to 5 years from the time of symptom onset
Establishing Asymchem’s first manufacturing footprint in Europe
The award recognizes powerful science–industry collaborations for social good
Cresset’s new India site will support the growing demands of Cresset’s APAC customer base
Collaboration to leverage AbbVie's psychiatry expertise and Gilgamesh's innovative research platform to develop next-generation neuroplastogens for the treatment of psychiatric disorders
Subscribe To Our Newsletter & Stay Updated
